Reuters logo
BRIEF-Fitch says Mylan's Epipen settlement removes major risk
October 10, 2016 / 6:26 PM / in a year

BRIEF-Fitch says Mylan's Epipen settlement removes major risk

Oct 10 (Reuters) - Fitch:

* Fitch: Mylan’s Epipen settlement moves major risk aside

* Mylan will have sufficient liquidity to make settlement payment without derailing expected de-leveraging subsequent to mostly debt-funded acquisition of Meda Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below